drugset / Trial / NCT00302666

Bleeding Pattern Study

NCT00302666

Phase 3 Completed 1315 enrolled Bayer
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake.

Timeline

Start
2003-06
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dienogest Small molecule 2 mg Oral
Comparator ethinyl estradiol Small molecule 0.03 mg Oral

Indications

No indication recorded.